m-t412
mAbexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 1995 (NCT00004816)
Timeline
1990s
- Jan 1, 1995
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- T-cell surface antigen CD4INHIBITOR
CD4 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- m-t412
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00004816 | Phase 1 | Jul 1, 1995 | National Center for Research Resources (NCRR), Stanford University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Center for Research Resources (NCRR) | Government | 1 | 1 | 1 | 1995 |
| Stanford University | Academic/Hospital | 1 | 0 | 1 | 1995 |
2 organizations
Page 1 / 1